Therefore, targeting key nodes within the macrophage metabolic-signaling network—such as PPARγ/CD36, Foxo1 phosphorylation, mitophagy, and glycolytic enzymes—may offer multi-mechanism therapeutic strategies for liver fibrosis. Here, PPARG is linked to Hepatic fibrosis.